0001600946-23-000001.txt : 20230626 0001600946-23-000001.hdr.sgml : 20230626 20230626124649 ACCESSION NUMBER: 0001600946-23-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plassche Douglas CENTRAL INDEX KEY: 0001600946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 231041054 MAIL ADDRESS: STREET 1: 165 LUDLOW AVE. CITY: NORTHVALE STATE: NJ ZIP: 07647 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-01-03 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001600946 Plassche Douglas 165 LUDLOW AVE. NORTHVALE NJ 07647 0 1 0 0 Executive VP Operations 0 Options 0.03 2023-01-03 4 A 0 7500000 0.03 A 2024-01-03 2033-01-03 Common Stock 7500000 7500000 D Options were awarded by the Board of Directions as part of Mr. Plassche's employment retention agreement. The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on January 3, 2024. Doug Plassche 2023-06-26